ImmuPharma (LON:IMM) Trading Up 191.7% – Time to Buy?

ImmuPharma plc (LON:IMM – Get Free Report)’s stock price rose 191.7% during trading on Thursday . The company traded as high as GBX 3.80 ($0.05) and last traded at GBX 3.50 ($0.04). Approximately 104,299,430 shares changed hands during mid-day trading, an increase of 470% from the average daily volume of 18,292,627 shares. The stock had previously closed at GBX 1.20 ($0.01).

ImmuPharma Price Performance

The firm’s 50 day simple moving average is GBX 1.40 and its two-hundred day simple moving average is GBX 1.65. The firm has a market capitalization of £15.30 million, a P/E ratio of -367.30 and a beta of 1.53.

About ImmuPharma

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Featured Stories

• Five stocks we like better than ImmuPharma
• Earnings Per Share Calculator: How to Calculate EPS
• Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
• What Are Some of the Best Large-Cap Stocks to Buy?
• Why Amazon’s Next Earnings Could Trigger a Stock Breakout
• Market Cap Calculator: How to Calculate Market Cap
• With This Kind of Data, The Fed Isn’t Cutting Rates This Year